Catalyst Event
Gilead Sciences Inc (GILD) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
6/4/2026, 12:00:00 AM
Completion of the acquisition of Ouro Medicines in collaboration with Lakefront Biotherapeutics to expand the inflammation pipeline with T-cell engager therapies on June 4, 2026. Low impact estimated as this is a small-scale strategic acquisition; expected.
Korean Translation
2026년 6월 4일, 레이크프론트 바이오테라퓨틱스(Lakefront Biotherapeutics)와 협력하여 T세포 인게이저 치료제로 염증 파이프라인을 확장하기 위한 오우로 메디슨스(Ouro Medicines) 인수 완료가 예상됨. 소규모 전략적 인수에 따른 낮은 영향이 예상됨.
Related Recent Events
Kinder Morgan Inc. (KMI) · Other
James Holland, Chief Operating Officer, is set to retire, effective September 4, 2026. Ken Grubb, currently VP and Chief Project Officer, will succeed him as COO. The transition was announced on April 22, 2026. Impact is estimated at 1% due to the planned nature of the succession scheduled.
9/4/2026, 12:00:00 AM
HEICO Corp (HEI) · Earnings Release
Q3 2026 earnings release on 2026-08-24 scheduled.
8/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Q2 FY2027 earnings release scheduled; medium impact from financial updates expected.
8/20/2026, 12:00:00 AM
Target Corp (TGT) · Earnings Release
Q2 2026 earnings release on August 19, 2026, with analysts forecasting an EPS of approximately $2.21-$2.25; low impact estimated as the market typically prices in consensus expectations prior to the release expected.
8/19/2026, 12:00:00 AM
CoreWeave Inc (CRWV) · Earnings Release
Q2 2026 earnings release for August 18, 2026, is of high importance as such releases often cause >10% price impact; event scheduled.
8/18/2026, 12:00:00 AM
Home Depot Inc. (The) (HD) · Earnings Release
Q2 2026 earnings release and conference call on August 18, 2026. Estimated price impact ~5% as earnings releases typically drive significant volatility; scheduled.
8/18/2026, 12:00:00 AM